# OGI Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ogi-bio

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.ogibio.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Mar 31, 2022)
- Investors on record: 6

## About

Based in Edinburgh, UK, and co-founded by Alex McVey (CEO) and Teuta Pilizota (CSO) in 2020, OGI Bio operates as a microbiology company offering automation of culturing microbes. In March 2022, the firm raised GBP 1 million in seed funding led by investor TRI Capital, with participation from other investors Apollo Informal Investment, Merleview Capital, Old College Capital, Sapphire Capital Partners, and Scottish Enterprise.

The company offers a modular and retrofittable device that redefines routine microbial culturing through BioReactor automation and analysis solutions. The company’s technology enables researchers and professionals to save time and enhance productivity. The OGI BioReactor is a hub for automation, and grows independent cultures of bacteria, yeast, algae, or fungi, with a focus on replicating routine methods while ensuring affordability. Additionally, OGI Bio's software packages offer enhanced remote and group control and analysis of systems, empowering users to increase throughput and reduce costs.

As of August 2023, the firm plans to launch another product called Increased Analytics.

## Funding rounds

- Seed, Mar 31, 2022, $1.3M — Old College Capital, Apollo Informal Investment, Sapphire Capital Partners, Scottish Enterprise, TRICAPITAL, Merleview Capital

## Investors

- Old College Capital (https://capitalatlas.ai/funds/old-college-capital) — Seed
- Apollo Informal Investment — Seed
- Sapphire Capital Partners (https://capitalatlas.ai/funds/sapphire-capital-partners) — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed
- TRICAPITAL (https://capitalatlas.ai/funds/tricapital) — Seed
- Merleview Capital — Seed